Zoono Group Ltd (ASX: ZNO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Zoono Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $23.97 million
P/E Ratio 28.90
Dividend Yield 0.00%
Shares Outstanding 406.21 million
Earnings per share -0.009
Dividend per share 0.03
Year To Date Return -25.32%
Earnings Yield 3.46%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Zoono Group Ltd (ASX: ZNO)
    Latest News

    a woman
    Share Market News

    This ASX biotech share just posted 144% half year revenue growth

    Shares in ASX biotech provider Zoono Group Ltd (ASX: ZNO) could move in early trade today after the group posted…

    Read more »

    a woman
    Share Market News

    Why the Zoono share price rocketed another 25% today

    The Zoono Group Ltd (ASX: ZNO) share price rocketed today after the company announced the appointment of an exclusive distributor…

    Read more »

    a woman
    Share Market News

    Why this small cap biotech has rocketed 2,511% in the last 5 months

    The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2020 $0.0300 0.00% Final 21 Sep 2020

    ZNO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Zoono Group Ltd

    Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.

    ZNO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Feb 2026 $0.06 $0.00 0.00% 103,189 $0.06 $0.06 $0.06
    26 Feb 2026 $0.06 $0.00 0.00% 55,830 $0.06 $0.06 $0.06
    25 Feb 2026 $0.06 $0.01 18.87% 27,489 $0.05 $0.06 $0.05
    24 Feb 2026 $0.05 $-0.01 -14.93% 279,341 $0.07 $0.07 $0.05
    23 Feb 2026 $0.07 $0.00 0.00% 71,045 $0.07 $0.07 $0.07
    20 Feb 2026 $0.07 $0.00 0.00% 39,046 $0.07 $0.07 $0.07
    19 Feb 2026 $0.07 $0.00 0.00% 40,798 $0.07 $0.07 $0.07
    18 Feb 2026 $0.07 $0.00 0.00% 15,000 $0.07 $0.07 $0.07
    17 Feb 2026 $0.07 $0.00 0.00% 39,020 $0.07 $0.07 $0.07
    16 Feb 2026 $0.07 $0.00 0.00% 153,178 $0.07 $0.07 $0.07
    13 Feb 2026 $0.07 $0.01 15.38% 165,803 $0.07 $0.07 $0.07
    12 Feb 2026 $0.07 $0.00 0.00% 264,761 $0.07 $0.07 $0.07
    10 Feb 2026 $0.07 $0.00 0.00% 7,730 $0.07 $0.07 $0.07
    09 Feb 2026 $0.07 $0.00 0.00% 21,830 $0.07 $0.07 $0.07
    06 Feb 2026 $0.07 $0.00 0.00% 7,139 $0.07 $0.07 $0.07
    05 Feb 2026 $0.07 $0.00 0.00% 673 $0.07 $0.07 $0.07
    04 Feb 2026 $0.07 $0.00 0.00% 755 $0.07 $0.07 $0.07
    03 Feb 2026 $0.07 $0.00 0.00% 205,361 $0.07 $0.07 $0.07
    02 Feb 2026 $0.07 $0.00 0.00% 84,352 $0.07 $0.07 $0.07
    30 Jan 2026 $0.07 $0.00 0.00% 122,255 $0.08 $0.08 $0.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Aug 2025 Donald Clarke Issued 72,322 $2,531
    Rights issue.
    05 Aug 2025 Elissa Hansen Issued 71,518 $2,503
    Rights issue.
    05 Aug 2025 Paul Hyslop Issued 14,921,072 $522,237
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Donald Ian Clarke Non-Executive Director Apr 2017
    Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group from 1988 until 2015. He is currently a consultant for the firm. Don has advised corporate clients on broad corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He is able to draw on his first-hand experience as a corporate lawyer and a company director in guiding the Company and the Board on the duties and responsibilities of the Directors and the best practice in corporate governance. He is the Chairman of the Risk Committee.
    Ms Elissa Hansen Company SecretaryNon Executive Director Aug 2015
    Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings practice governance advice, ensuring compliance with the Listing Rules, Corporations Act and other relevant legislation. She is a member of the Risk Committee.
    Mr Paul Hyslop Managing Director Apr 2017
    Mr Hyslop prior to establishing Zoono, Paul was involved in several entrepreneurial ventures ranging from the establishment of a private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002 - 2005. Adept at dealing with businesses and consumers alike, he co-established the Business Brokerage Division at Bayley's Real Estate - real estate and business brokerages in New Zealand. Paul's experience in business development dates to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
    Mr Marc Braterman Non-Executive Director Feb 2026
    Mr Braterman is the Founder and Chief Executive Officer of OSY Group Limited. Marc has worked closely with Zoonos management team throughout this development phase, contributing to product strategy, commercial positioning, and partner engagement.
    Mr Barry Woolcott Global General ManagerChief Executive Officer Mar 2022
    -
    Paul Ravlich Chief Financial Officer
    -
    Lew Mackinnon Chief Operations Officer
    -
    Barry Woolcott Global General ManagerChief Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paul Russell Hyslop & Margaret Jane Morgan & Npt Meg Trustee Limited <Meg A/C> 104,447,500 29.39%
    Citicorp Nominees Pty Limited 48,494,639 13.64%
    BNP Paribas Noms Pty Ltd 44,232,321 12.45%
    Mrs Barbara Diane Wiersma & Mr Eelco Wiersma 17,493,204 4.92%
    Mr Theophilos Papantoniou 4,975,180 1.40%
    Marissa Tacy Muirhead 4,118,889 1.16%
    Sharesies Australia Nominee Pty Limited 4,042,294 1.14%
    Lewis Andrew Craig Mackinnon 3,867,131 1.09%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 3,619,340 1.02%
    Lordmax Pty Ltd <Al Fund A/C> 3,600,000 1.01%
    Ms Marie Tania Adams 3,572,155 1.00%
    Ravlich Trustee Limited 2,828,023 0.80%
    Mr Andrew Lozynsky 2,200,000 0.62%
    Mr Libor Jelenek 2,000,000 0.56%
    Mr Ronald Duje Vela 1,951,852 0.55%
    Woolcott Investments Limited <The Woolcott Investment A/C> 1,886,792 0.53%
    Mr Martin Hunt 1,716,204 0.48%
    Mr Eelco Wiersma & Mr Malcolm Hinman <Christchurch United A/C> 1,700,000 0.48%
    Leslie Allan Black 1,388,889 0.39%
    Mr Shaileshkumar Shankarbhai Patel 1,341,372 0.38%

    Profile

    since

    Note